Dudediligence.

Cue Biopharma, Inc

CUENASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$1,864,384

3 notices · 74,317 sh

Oct 2025 to Oct 2026

Reported ·

$99,719

0 sales · 5 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-12: Shao-Lee Lin, Form 1442026-08-13: Sumita Ray, Form 1442025-12-29: MATTEO GIACOMO LEVISETTI, Form 1442025-12-30: Sarraf Pasha, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-08-13Sumita Ray, Chief Legal Compliance Officer$266,106
8,829 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-12Shao-Lee Lin, Chief Executive Officer$1,596,371
58,258 shno plan dateForm 4s on file end Jun 23144 ↗
2025-12-29MATTEO GIACOMO LEVISETTI, Chief Medical Officer$1,907
7,230 shno plan dateno Form 4 on file144 ↗